Position in ASND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,157,945,625
+$68,052,316 QoQ
Shares Held
5,062,500
-1.0% QoQ
Ownership
7.72%
of shares outstanding
% of Portfolio
11.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Derivatives in ASND
reported options exposure · as of Dec 31, 2025CallValue
$10,662,000
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Avoro Capital Advisors LLC holds $8,549,473,651 across 28 Biotechnology names. ASND ranks #1 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
This page
|
5,062,500 | $1,157,945,625 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,818,181 | $951,763,208 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
2,888,888 | $746,257,548 | |
| 4 | ARGX |
Argenx SE
|
1,000,000 | $730,250,000 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
10,699,999 | $670,889,937 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
7,474,747 | $622,571,677 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
12,222,222 | $491,699,991 | |
| 8 | CNTA |
Centessa Pharmaceuticals plc
|
11,430,455 | $454,017,672 |
All Filings in ASND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,157,945,625 | 5,062,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,662,000 | 50,000 | Call | Sole | 2026-03-16 | |
| 2025-12-31 | $1,089,893,309 | 5,111,111 | Shares | Sole | 2026-03-16 | |
| 2025-09-30 | $1,015,919,100 | 5,110,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $859,548,000 | 4,980,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $813,277,480 | 5,218,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $702,537,581 | 5,103,055 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $744,890,867 | 4,988,888 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $572,340,627 | 4,196,661 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $599,640,899 | 3,966,666 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $473,012,152 | 3,755,555 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $343,658,800 | 3,670,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $319,564,533 | 3,580,555 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $356,506,500 | 3,325,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $378,603,000 | 3,100,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $294,291,000 | 2,850,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $211,484,000 | 2,275,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $258,192,000 | 2,200,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $269,060,000 | 2,000,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $315,592,200 | 1,980,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $249,945,000 | 1,900,000 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $300,204,000 | 1,800,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $277,776,000 | 1,800,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $258,825,000 | 1,750,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $201,234,070 | 1,787,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||